Annals of Oncology

Editorials:

D. J. Kerr and D. Khayat

The Entente Cordiale—natural and necessary
Ann Oncol 15: 1581; doi:10.1093/annonc/mdh446
[Extract] [FREE Full Text] [PDF] [Request Permissions]

F. Joly and I. F. Tannock

Chemotherapy for patients with hormone-refractory prostate cancer
Ann Oncol 15: 1582-1584; doi:10.1093/annonc/mdh445
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

S. S. Wöhrer, M. Raderer, and M. Hejna

Palliative chemotherapy for advanced gastric cancer
Ann Oncol 15: 1585-1595; doi:10.1093/annonc/mdh422
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Z. Chouliara, N. Kearney, D. Stott, A. Molassiotis, and M. Miller

Perceptions of older people with cancer of information, decision making and treatment: a systematic review of selected literature
Ann Oncol 15: 1596-1602; doi:10.1093/annonc/mdh423
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Special articles:

ESMO/ASCO Task Force on Global Curriculum in Medical Oncology, H. H. Hansen, D. F. Bajorin, H. B. Muss, G. Purkalne, D. Schrijvers, and R. Stahel

Recommendations for a Global Core Curriculum in Medical Oncology
Ann Oncol 15: 1603-1612; doi:10.1093/annonc/mdh447
[Extract] [FREE Full Text] [PDF] Translations [Request Permissions]

Original articles:

Urogenital tumors:

R. P. Abratt, D. Brune, M.-A. Dimopoulos, J. Kliment, J. Breza, F. P. Selvaggi, P. Beuzeboc, T. Demkow, and S. Oudard

Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancer
Ann Oncol 15: 1613-1621; doi:10.1093/annonc/mdh429
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Breast cancer:

M. Erman, H. Abali, B. Oran, I. C. Haznedaroglu, H. Canpinar, S. Kirazli, and I. Celik

Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?
Ann Oncol 15: 1622-1626; doi:10.1093/annonc/mdh437
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Schneeweiss, I. Diel, M. Hensel, S. Kaul, H.-P. Sinn, K. Unnebrink, C. Rudlowski, I. Lauschner, F. Schuetz, G. Egerer, R. Haas, A. D. Ho, and G. Bastert

Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy
Ann Oncol 15: 1627-1632; doi:10.1093/annonc/mdh433
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. Colleoni, N. Rotmensz, G. Peruzzotti, P. Maisonneuve, G. Viale, G. Renne, C. Casadio, P. Veronesi, M. Intra, R. Torrisi, and A. Goldhirsch

Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies
Ann Oncol 15: 1633-1639; doi:10.1093/annonc/mdh434
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

K. Slimane, F. Andre, S. Delaloge, A. Dunant, A. Perez, J. Grenier, C. Massard, and M. Spielmann

Risk factors for brain relapse in patients with metastatic breast cancer
Ann Oncol 15: 1640-1644; doi:10.1093/annonc/mdh432
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Lung cancer:

N. Lorent, P. De Leyn, Y. Lievens, E. Verbeken, K. Nackaerts, C. Dooms, D. Van Raemdonck, B. Anrys, J. Vansteenkiste, and The Leuven Lung Cancer Group

Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience
Ann Oncol 15: 1645-1653; doi:10.1093/annonc/mdh435
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

B. Vischioni, P. van der Valk, S. W. Span, F. A. E. Kruyt, J. A. Rodriguez, and G. Giaccone

Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer
Ann Oncol 15: 1654-1660; doi:10.1093/annonc/mdh436
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gastrointestinal tumors:

W. Yeo, K. C. Lam, B. Zee, P. S. K. Chan, F. K. F. Mo, W. M. Ho, W. L. Wong, T. W. T. Leung, A. T. C. Chan, B. Ma, T. S. K. Mok, and P. J. Johnson

Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy
Ann Oncol 15: 1661-1666; doi:10.1093/annonc/mdh430
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Sarcomas:

S. R. Grobmyer, R. G. Maki, G. D. Demetri, M. Mazumdar, E. Riedel, M. F. Brennan, and S. Singer

Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma
Ann Oncol 15: 1667-1672; doi:10.1093/annonc/mdh431
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

J. Teruya-Feldstein, E. Chiao, D. A. Filippa, O. Lin, R. Comenzo, M. Coleman, C. Portlock, and A. Noy

CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients
Ann Oncol 15: 1673-1679; doi:10.1093/annonc/mdh399
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. Wöhrer, A. Chott, J. Drach, A. Püspök, M. Hejna, M. Hoffmann, and M. Raderer

Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma
Ann Oncol 15: 1680-1683; doi:10.1093/annonc/mdh427
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

R. Stasi, M. Brunetti, E. Terzoli, E. Abruzzese, and S. Amadori

Once-weekly dosing of recombinant human erythropoietin alpha in patients with myelodysplastic syndromes unresponsive to conventional dosing
Ann Oncol 15: 1684-1690; doi:10.1093/annonc/mdh428
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

W. Brugger, J. Hirsch, F. Grünebach, R. Repp, P. Brossart, W. Vogel, H.-G. Kopp, M. G. Manz, M. Bitzer, G. Schlimok, M. Kaufmann, A. Ganser, K. Fehnle, M. Gramatzki, and L. Kanz

Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study
Ann Oncol 15: 1691-1698; doi:10.1093/annonc/mdh425
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

R. Munker, J. Glass, L. K. Griffeth, T. Sattar, R. Zamani, M. Heldmann, R. Shi, and D. L. Lilien

Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease
Ann Oncol 15: 1699-1704; doi:10.1093/annonc/mdh426
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

S. D. Undevia, H. L. Kindler, L. Janisch, S. C. Olson, R. L. Schilsky, N. J. Vogelzang, K. A. Kimmel, T. A. Macek, and M. J. Ratain

A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine
Ann Oncol 15: 1705-1711; doi:10.1093/annonc/mdh438
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Epidemiology:

M. Malvezzi, C. Bosetti, L. Chatenoud, T. Rodríguez, F. Levi, E. Negri, and C. La Vecchia

Trends in cancer mortality in Mexico, 1970–1999
Ann Oncol 15: 1712-1718; doi:10.1093/annonc/mdh424
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

J. A. Menendez, S. Ropero, R. Lupu, and R. Colomer

Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells
Ann Oncol 15: 1719-1721; doi:10.1093/annonc/mdh442
[Extract] [FREE Full Text] [PDF] [Request Permissions]

B. Yalcin, A. Büyükçelik, and G. Utkan

Expression of Cox-2 protein in radioresistant laryngeal cancer
Ann Oncol 15: 1721; doi:10.1093/annonc/mdh439
[Extract] [FREE Full Text] [PDF] [Request Permissions]

P. Nix

Comments on "Expression of Cox-2 protein in radioresistant laryngeal cancer" (Ann Oncol 2004; 15: 1721)
Ann Oncol 15: 1721-1722; doi:10.1093/annonc/mdh441
[Extract] [FREE Full Text] [PDF] [Request Permissions]

F. Perrone, M. Marangolo, F. Di Costanzo, G. Colucci, L. Repetto, M. Merlano, S. De Placido, V. Torri, G. Comella, R. Labianca, V. Parisi, and C. Gallo

Insurance for independent cancer trials
Ann Oncol 15: 1722-1723; doi:10.1093/annonc/mdh444
[Extract] [FREE Full Text] [PDF] [Request Permissions]

N. Frickhofen

t(14;18) and bcl-2 should not be used synonmously
Ann Oncol 15: 1723; doi:10.1093/annonc/mdh440
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

U. Tirelli

Fatigue in Cancer
Ann Oncol 15: 1725; doi:10.1093/annonc/mdh443
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.